Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
1-15 of 2101 results
Bristol-Myers Squibb, CytomX extend cancer collaboration
By PBR Staff Writer
Bristol-Myers Squibb (BMS) is paying CytomX Therapeutics $200m upfront to add up to eight new candidates to their existing Probody therapeutics collaboration.
Contract Research & Services > Contract Research > News
Novimmune, LegoChem to collaborate on antibody drug conjugate research
Swiss biotech company Novimmune and South Korea based LegoChem Biosciences (LCB) have entered into a research collaboration to evaluate an antibody drug conjugate candidate.
Contract Research & Services > Contract Research > News
Heptares Therapeutics, University of Cambridge launch research collaboration
By PBR Staff Writer
Heptares Therapeutics has partnered with the University of Cambridge to discover molecules that modulate a cardiovascular target.
Contract Research & Services > Contract Research > News
Immune Pharmaceuticals enters research collaboration for antibodies in cancer
By PBR Staff Writer
Immune Pharmaceuticals has partnered with a French Technology Transfer Office to develop mono- and bispecific antibodies against novel targets in the tumor microenvironment.
Contract Research & Services > Contract Research > News
Gilead awards more than $22m in grants to support HIV cure research
US biopharmaceutical firm Gilead Sciences has awarded more than $22m in grants to support 12 new HIV cure research projects.
Contract Research & Services > Contract Research > News
Ipsen to buy Merrimack's global oncology assets
Ipsen has agreed to acquire global oncology assets from Merrimack Pharmaceuticals, including its key marketed product ONIVYDE (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy, in combination with fluorouracil and leucovorin.
Contract Research & Services > Contract Research > News
Bristol-Myers, Janssen enter into new immunotherapy clinical research collaboration
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and Janssen Biotech are expanding their clinical research collaboration, which was announced in July 2016, with new combo trials.
Contract Research & Services > Contract Research > News
Ionis earns $5m milestone payment from Jannsen under GI collaboration
Ionis Pharmaceuticals has earned $5m milestone payment from Janssen Biotech towards validation of an undisclosed target to treat patients with a gastrointestinal (GI) autoimmune disease.
Contract Research & Services > Contract Research > News
Research shows flickering lights could be used in Alzheimer's treatment
By PBR Staff Writer
Researchers at the Massachusetts Institute of Technology (MIT) have discovered a non-invasive visual stimulation technique that can be potentially used for treating Alzheimer’s disease.
Contract Research & Services > Contract Research > News
Oxford BioMedica partners with Orchard Therapeutics
Gene and cell therapy firm Oxford BioMedica has partnered with Orchard Therapeutics, a clinical-stage biotechnology firm dedicated to bringing transformative ex-vivo gene therapies to patients with severe and life-threatening orphan diseases.
Contract Research & Services > Contract Research > News
GeoVax, ViaMune to partner on cancer immunotherapy program
GeoVax Labs and ViaMune are collaborating on cancer immunotherapy programs.
Contract Research & Services > Contract Research > News
Cannabis Science to start in-house clinical research with IGXBio's immunotherapy
Cannabis Science said its in-house lab is almost complete and has started clinical development plans to start working with its partner IGXBio to develop effective cannabinoid therapeutics using IGXBio's Immunotherapy (GenePro, also referred to as Δ4SHIVKU2) FDA Investigational New Drug (IND) Number 015982.
Contract Research & Services > Contract Research > News
IFM Therapeutics establishes German subsidiary and research site in Bonn
IFM Therapeutics has established a German subsidiary, IFM Therapeutics, and a research site at the Institute of Innate Immunity within the University of Bonn.
Contract Research & Services > Contract Research > News
Oasmia enters into collaboration deal with Karo Pharma for cancer project
Oasmia Pharmaceutical and Karo Pharma have signed an agreement concerning Karo Pharma’s cancer project KB9520, which has demonstrated promising results in pre-clinical models for several types of cancer.
Contract Research & Services > Contract Research > News
EnGenelC enters into research collaboration with Takeda
EnGeneIC has entered into a research collaboration with, and granted an exclusive licence option to, Takeda Pharmaceutical Company to develop its EDV nanocell platform for targeted cyto-immunotherapy in cancer.
Contract Research & Services > Contract Research > News
1-15 of 2101 results